Mizuho Issues Positive Forecast for Cardinal Health (NYSE:CAH) Stock Price

Cardinal Health (NYSE:CAH) had its target price upped by research analysts at Mizuho from $142.00 to $150.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Mizuho’s price objective would suggest a potential upside of 9.95% from the company’s previous close.

Other analysts also recently issued reports about the stock. Morgan Stanley upped their target price on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a research report on Friday, January 31st. JPMorgan Chase & Co. raised their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Citigroup upped their price target on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research note on Friday, January 10th. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $132.00 to $145.00 in a research note on Monday, January 6th. Finally, TD Cowen raised Cardinal Health from a “hold” rating to a “buy” rating and increased their target price for the stock from $130.00 to $144.00 in a research note on Wednesday, January 8th. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $140.14.

Cardinal Health Price Performance

Shares of CAH opened at $136.43 on Monday. The company has a 50-day simple moving average of $128.36 and a two-hundred day simple moving average of $120.86. The firm has a market capitalization of $32.96 billion, a PE ratio of 25.45, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. Cardinal Health has a one year low of $93.17 and a one year high of $137.18.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Analysts expect that Cardinal Health will post 7.95 EPS for the current fiscal year.

Hedge Funds Weigh In On Cardinal Health

Several hedge funds and other institutional investors have recently bought and sold shares of CAH. Cyrus J. Lawrence LLC purchased a new position in shares of Cardinal Health during the fourth quarter valued at approximately $26,000. Promus Capital LLC bought a new stake in Cardinal Health in the 4th quarter worth approximately $30,000. Bellwether Advisors LLC purchased a new stake in Cardinal Health during the 4th quarter valued at $32,000. Lee Danner & Bass Inc. bought a new position in shares of Cardinal Health during the 4th quarter valued at $35,000. Finally, Itau Unibanco Holding S.A. purchased a new position in shares of Cardinal Health in the 4th quarter worth $36,000. Institutional investors own 87.17% of the company’s stock.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.